Description of Pinealon

Pinealon is a synthetic tripeptide, likely developed within the framework of geroprotective substance research in Russia, aimed at identifying compounds that slow the aging process and enhance cognitive functions. The peptide has demonstrated significant promise in the field of neuroprotection, particularly regarding its ability to safeguard cells from damage induced by aging or oxidative stress.

One of the primary effects of Pinealon is its ability to influence the function of the pineal gland, which regulates circadian rhythms and biological processes within the body. Due to this capability, Pinealon may contribute to improved sleep quality, regulation of bodily rhythms, and enhanced regeneration during sleep. Research has shown that Pinealon holds anti-aging potential, particularly within the central nervous system, where it may aid in enhancing cognitive functions such as memory and learning.

Research Confirmed Effects 

1. Pinealon and DNA

Pinealon does not, unlike most peptides, interact with cell surface or cytoplasmic receptors, raising questions about its mechanism of action. It was previously hypothesized that its small size allows it to pass through lipid bilayers, such as cellular and nuclear membranes, and potentially interact directly with DNA. Research on cell cultures, specifically HeLa cells, has confirmed that Pinealon can penetrate not only the cytoplasm but also the nucleus, where it affects genetic information. This discovery explains how Pinealon can function as a gene expression regulator, offering new insight into its wide range of effects, which are not the result of interaction with traditional receptors.

In experiments where peptides were labeled with fluorescein, significant fluorescence was observed in both the cytoplasm and nucleus of cells, suggesting that these short biologically active peptides can penetrate the cytoplasm and nucleus, interacting with various components, including DNA and RNA. Analysis of these interactions revealed that peptides like Pinealon can specifically bind to nucleotide sequences, including those with a cytosine methylation state. This mechanism may epigenetically regulate gene activity, highlighting the significant role of Pinealon in regulating gene expression and genetic functions critical for cell development and evolution.

[1]

2. Pinealon and its Effect on Aging

Pinealon demonstrates strong anti-aging effects, particularly in the central nervous system, as confirmed by research indicating that this peptide may help slow biological aging. Studies from Russia suggest that Pinealon, along with a similar peptide, Vesugen, exhibits anabolic effects in the brain and may improve cognitive functions, thereby slowing the rate of aging based on biological markers. Additionally, Pinealon also has effects on muscle cells, where it influences the expression of irisin, a hormone that protects muscles during physical activity, promotes fat burning, and helps extend telomeres, further contributing to slowing aging and combating oxidative stress.

Research has also shown that plasma levels of irisin are directly associated with telomere length, suggesting that Pinealon may play a key role in the epigenetic regulation of aging. Interestingly, irisin is active not only in muscle cells but also in other tissues, which may explain the widespread effects of Pinealon throughout the body, including the brain. Thus, this peptide offers potential for improving overall bodily condition, extending cell lifespan, and enhancing metabolic processes, showing promise in improving energy balance and supporting health during the aging process.

[2] - [4]

3. Pinealon and Neurons

Research on rats has shown that administering Pinealon to pregnant female rats with a methionine-enriched diet significantly improved cognitive functions and motor coordination in their offspring. Pinealon helps protect neurons from oxidative stress, reducing the accumulation of reactive oxygen species and necrotic cell death in the brain. These effects provide evidence of the neuroprotective properties of Pinealon and suggest that this peptide may be effective in protecting nerve cells from stress-induced damage.

Further research confirmed that Pinealon enhances neuronal resistance to hypoxic stress by stimulating antioxidant enzyme systems in the body and limiting the excitotoxic effects of N-methyl-D-aspartate (NMDA). NMDA is known to cause neuronal damage in various neurodegenerative diseases. Additionally, Pinealon stimulates the production of irisin, a hormone released from skeletal muscles during exercise, which has a positive impact on cell protection, fat burning, and telomere extension. Increased levels of irisin in the brain may lead to improved memory and learning, thus promoting overall central nervous system health. This research indicates that Pinealon could be an important tool for neuron protection and slowing the aging processes in the brain.

[5] - [8]

4. Pinealon and Symptoms of Depression

The peptides Glu-Asp-Arg (Penealon) and Lys-Glu-Asp have demonstrated the ability to stimulate serotonin expression in aging cortical cell cultures, regulating the gene for 5-hydroxytryptophanase, which is crucial for serotonin synthesis. Molecular docking studies revealed that the nucleotide sequence CCTGCC in the 5-hydroxytryptophanase gene is complementary to these peptides, suggesting that the epigenetic regulation of serotonin synthesis could be the basis for the neuroprotective and geroprotective effects of these peptides.

Further research in cortical cell cultures suggests that Pinealon may support serotonin production through epigenetic changes, thereby increasing the activity of 5-hydroxytryptophanase. This process is essential not only for the neuroprotective effects of serotonin but also for its potential use in combating depression, where naturally increasing serotonin production could reduce the need for selective serotonin reuptake inhibitors (SSRIs) and their side effects.

[9]

5. Pinealon and Cell Death

Research on the effects of Pinealon (Glu-Asp-Arg) has shown its significant potential in regulating cognitive functions and protecting brain cells from damage caused by hypoxia. Studies on rats have indicated that this peptide enhances neurogenesis and alleviates neuroinflammatory responses in acute hypoxia, leading to improved cognitive abilities and protection against oxidative stress. Pinealon reduces reactive oxygen species (ROS) in brain tissue, thereby alleviating apoptosis and protecting neurons from damage, which supports its neuroprotective effects. This mechanism is also confirmed by its effects on the inhibition of caspase-3, a key enzyme responsible for cell death.

In addition to its neuroprotective effects, Pinealon has proven effective in other cell types, including those involved in tissue regeneration. Research on rat skin cultures has shown that Pinealon promotes cell proliferation and reduces apoptosis, enhancing regenerative processes in the skin. This effect is significant in treating age-related skin pathologies, with studies showing that Pinealon increases cell proliferation even in older animals, accelerating healing. In combination with its effects on the brain, Pinealon may contribute to overall tissue regeneration improvement and the reduction of aging effects.

Pinealon also demonstrates further therapeutic potential in the field of cardiology. In experiments with myocardial infarction, the peptide was shown to reduce caspase-3 levels, suggesting it may decrease apoptosis of cardiac myocytes and improve tissue regeneration after a heart attack. This effect is crucial not only in protecting against initial damage during the infarction but also in preventing long-term consequences such as myocardial remodeling, which leads to permanent dysfunctions. Therefore, Pinealon could play a key role in the treatment and prevention of damage associated with acute myocardial infarction and its aftermath.

These studies suggest the broad therapeutic potential of Pinealon, which could be beneficial not only in neuroprotective therapies but also in tissue regeneration and the treatment of conditions related to tissue damage, such as heart attacks or chronic injuries. This peptide could be part of new approaches in aging treatment and cell regeneration improvements, contributing to enhanced overall health and quality of life. 

[10] - [12]

6. Pinealon and Its Effect on Sleep 

A study focusing on the impact of Pinealon and Cortexin on neurobehavioral status revealed significant differences in the prevalence of psychological disorders between truck drivers and machinists. Truck drivers showed a markedly higher incidence of unstable psychological adaptation and borderline mental disorders compared to the control group. The findings suggest that the main factors affecting the emotional and psychological balance of truck drivers were work-related risks and long-term exposure to stress associated with their work schedule. In contrast, age was the significant factor among machinists. The study also demonstrated that bioregulatory peptides, such as Pinealon, can restore the body’s adaptive potential, improve emotional well-being, and enhance resistance to work-related stress.

In addition to improving psychoemotional indicators, it was shown that Pinealon also positively affects the regulation of sleep cycles, which is particularly important for individuals with sleep disorders caused by irregular work schedules or other factors. Research suggests that Pinealon can restore proper pineal gland function, leading to improvements in sleep quality, mood, blood pressure, and overall health. This effect is crucial as disrupted sleep is associated with many negative health outcomes, including impaired cognition and increased risk of heart disease. Based on these results, Pinealon presents a promising agent for alleviating the consequences of work-related risks and sleep disturbances, contributing to better physical and mental health for workers and patients with health conditions affecting sleep cycles.

[13]

References

1. L. I. Fedoreyeva, I. I. Kireev, V. K. Khavinson, and B. F. Vanyushin, “Penetration of short fluorescence-labeled peptides into the nucleus in HeLa cells and in vitro specific interaction of the peptides with deoxyribooligonucleotides and DNA,” Biochem. Biokhimiia, vol. 76, no. 11, pp. 1210–1219, Nov. 2011.
2. V. N. Meshchaninov, E. L. Tkachenko, S. V. Zharkov, I. V. Gavrilov, and I. E. Katyreva, “[EFFECT OF SYNTHETIC PEPTIDES ON AGING OF PATIENTS WITH CHRONIC POLYMORBIDITY AND ORGANIC BRAIN SYNDROME OF THE CENTRAL NERVOUS SYSTEM IN REMISSION],” Adv. Gerontol. Uspekhi Gerontol., vol. 28, no. 1, pp. 62–67, 2015.
3. V. K. Khavinson, B. I. Kuznik, S. I. Tarnovskaya, and N. S. Lin’kova, “Short Peptides and Telomere Length Regulator Hormone Irisin,” Bull. Exp. Biol. Med., vol. 160, no. 3, pp. 347–349, Jan. 2016.
4. K. S. Rana et al., “Plasma irisin levels predict telomere length in healthy adults,” Age Dordr. Neth., vol. 36, no. 2, pp. 995–1001, Apr. 2014.
5. A. Arutjunyan, L. Kozina, S. Stvolinskiy, Y. Bulygina, A. Mashkina, and V. Khavinson, “Pinealon protects the rat offspring from prenatal hyperhomocysteinemia,” Int. J. Clin. Exp. Med., vol. 5, no. 2, pp. 179–185, 2012.
6. V. Khavinson et al., “Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes,” Rejuvenation Res., vol. 14, no. 5, pp. 535–541, Oct. 2011.
7. L. S. Kozina, “[Investigation of antihypoxic properties of short peptides],” Adv. Gerontol. Uspekhi Gerontol., vol. 21, no. 1, pp. 61–67, 2008.
8. J. Zhang and W. Zhang, “Can irisin be a linker between physical activity and brain function?,” Biomol. Concepts, vol. 7, no. 4, pp. 253–258, Aug. 2016.
9. V. K. Khavinson, N. S. Lin’kova, S. I. Tarnovskaya, R. S. Umnov, E. V. Elashkina, and A. O. Durnova, “Short peptides stimulate serotonin expression in cells of brain cortex,” Bull. Exp. Biol. Med., vol. 157, no. 1, pp. 77–80, May 2014.
10. A. M. Mendzheritskiĭ, G. V. Karantysh, G. A. Ryzhak, and S. V. Dem’ianenko, “[Regulation of content of cytokines in blood serum and of caspase-3 activity in brains of old rats in model of sharp hypoxic hypoxia with Cortexin and Pinealon],” Adv. Gerontol. Uspekhi Gerontol., vol. 27, no. 1, pp. 94–97, 2014.
11. “Serum Caspase-3 p17 Fragment Is Elevated in Patients With ST-Segment Elevation Myocardial Infarction | JACC: Journal of the American College of Cardiology.” [Online]. Available: http://www.onlinejacc.org/content/57/2/220. [Accessed: 11-Jun-2019].
12. M. A. Voicekhovskaya, N. I. Chalisova, E. A. Kontsevaya, and G. A. Ryzhak, “Effect of bioregulatory tripeptides on the culture of skin cells from young and old rats,” Bull. Exp. Biol. Med., vol. 152, no. 3, pp. 357–359, Jan. 2012.
13. A. S. Bashkireva and V. G. Artamonova, “[The peptide correction of neurotic disorders among professional truck-drivers],” Adv. Gerontol. Uspekhi Gerontol., vol. 25, no. 4, pp. 718–728, 2012.